Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/8/2022 | Market Perform → Market Outperform | CJS Securities | |
| 8/29/2022 | Market Outperform → Market Perform | CJS Securities |
Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32
Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%
Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl
4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)
4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)
4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)
CJS Securities upgraded Wiley from Market Perform to Market Outperform
CJS Securities downgraded Wiley from Market Outperform to Market Perform
8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)
10-Q - JOHN WILEY & SONS, INC. (0000107140) (Filer)
8-K - JOHN WILEY & SONS, INC. (0000107140) (Filer)
4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)
4/A - JOHN WILEY & SONS, INC. (0000107140) (Issuer)
4 - JOHN WILEY & SONS, INC. (0000107140) (Issuer)
Company recently reported strong Q2 margin expansion and reaffirmed full year earnings and free cash flow guidance Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that it has boosted its Fiscal 2026 share repurchase allocation to $100 million, up from $60 million in Fiscal 2025 and $45 million in Fiscal 2024. Wiley has already executed approximately $35 million of this allocation in the first half with an objective of executing $65 million through the rest of the fiscal year ending April 30, 2026. In the first half, the Company raised its quarterly dividend for the 32
Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the second quarter ended October 31, 2025. SECOND QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $422 million vs. $427 million including foregone revenue of $3 million from divested businesses; Operating Income of $73 million up 14%; and Diluted Earnings Per Share (EPS) of $0.84 up 14% Adjusted Results at constant currency: Adjusted Revenue of $422 million down 1% with solid Research growth more than offset by market-related declines in Learning; Adjusted Operating Income of $79 million up 14%
Wiley (NYSE:WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its second quarter 2026 results prior to market open on Thursday, December 4, 2025. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at https://events.q4inc.com/attendee/792761606 US and Canada callers, please dial (888) 210-3346 and enter the participant code 2521217#. Or International callers, please dial (646) 960-0253 and enter the participant code 2521217#. ABOUT WILEY Wiley (NYSE:WLY) is a gl
SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)
SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)
SC 13G/A - JOHN WILEY & SONS, INC. (0000107140) (Subject)
Chief Digital & Analytics Officer for The Cigna Group has strong background in technology and AI innovation Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Katya Andresen, chief digital & analytics officer for The Cigna Group, to its Board of Directors. Andresen's background spans technology, data, analytics, and AI innovation across Fortune 500 companies and emerging enterprises. She has led significant initiatives at The Cigna Group and Capital One and successfully transformed Cricket Media by launching a profitable data and digital licensing business. "As we continue to advance our priorities
Seasoned finance executive brings a proven track record in driving profitable growth, improving operational efficiency, and optimizing cash flow Wiley (NYSE:WLY), one of the world's largest publishers and a global leader in research and education, today announced the appointment of Craig Albright as executive vice president and chief financial officer, effective June 26, 2025. Chris Caridi, who has led Wiley's finance organization as interim chief financial officer, will continue with the role of senior vice president, chief accounting officer and finance transformation leader. Albright joins Wiley with over 30 years of global leadership expertise in finance, strategy, and consulting ro
MilliporeSigma Chief Technology Officer Brings Extensive Science, Technology, and Innovation Leadership Experience Wiley (NYSE:WLY), one of the world's largest publishers and a trusted leader in research and learning, today announced the appointment of Karen N. Madden, Ph.D., to its Board of Directors. Madden is Senior Vice President and Chief Technology Officer at MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany. At MilliporeSigma, Madden shapes the Technology Roadmap and long-term R&D strategy, systematically exploring emerging opportunities that lead to breakthrough innovations. She leads the Life Science Innovation Board, ensuring a balance o